Journal
JHEP REPORTS
Volume 2, Issue 3, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.jhepr.2020.100101
Keywords
Alcohol; ALD; ASH; NASH; NAFLD; metabolic syndrome; obesity; diabetes
Categories
Ask authors/readers for more resources
While metabolic syndrome and alcohol consumption are the two main causes of chronic liver disease, one of the two conditions is often predominant, with the other acting as a cofactor of morbimortality. It has been shown that obesity and alcohol act synergistically to increase the risk of fibrosis progression, hepatic carcinogenesis and mortality, while genetic polymorphisms can strongly influence disease progression. Based on common pathogenic pathways, there are several potential targets that could be used to treat both diseases; based on the prevalence and incidence of these diseases, new therapies and clinical trials are needed urgently. (C) 2020 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available